Editor’s note. Alliance Defending Freedom responded yesterday to the opening briefs the U.S. Department of Justice and Danco Laboratories filed Tuesday with the U.S. Supreme Court in U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine.
“Women and girls should have the ongoing care of a doctor when taking high-risk drugs,” said Alliance Defending Freedom Senior Counsel Erin Hawley, vice president of the Center for Life and Regulatory Practice. “But the Biden administration is defending the FDA’s reckless removal of the safety standards it originally deemed necessary for women who use abortion drugs. The FDA’s own label for these drugs says that roughly one in 25 women who take them will end up in the emergency room. The agency’s removal of in-person doctor visits and consistent, ongoing care has subjected more women to suffering severe, even life-threatening, medical conditions.”
Hawley concluded, “Regardless of Americans’ beliefs about abortion, no one should be okay with the FDA leaving girls to take these high-risk drugs all alone. We urge the Supreme Court to hold the FDA accountable and require the agency to reinstate its safety standards.”